Skip to content

Study · Animal study (in vivo) · rat · 1998

4 results

Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release.

Torsello A, Luoni M, Schweiger F, Grilli R, Guidi M, Bresciani E, Deghenghi R, Müller EE, Locatelli V

European journal of pharmacology1 Nov 1998Cited by 59 (Europe PMC)

PMID9851578 (opens in a new tab)DOI10.1016/s0014-2999(98)00677-3 (opens in a new tab)PepBankPUB-09851578
Publisher pagePubMedAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In satiated rats, subcutaneous GHRP‑6 dose dependently stimulated GH release.

    In plain wordsIn rats, GHRP‑6 injected under the skin raised growth hormone release in a dose-dependent way.

    Peptide
    GHRP-6
    Outcome
    IncreaseGH release after subcutaneous GHRP-6
    Study

    ratn: not reported in source

    satiated rats
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated · subcutaneousAs given in this study (rat).

    Source sentences

    Summary
    Two well-known hexapeptides, GHRP-6 and hexarelin, given s.c., dose dependently stimulated both GH release and feeding behavior in satiated rats.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In satiated rats, subcutaneous GHRP‑6 dose dependently stimulated feeding behavior.

    In plain wordsIn rats that were not hungry, GHRP‑6 injected under the skin made them eat more in a dose-dependent way.

    Peptide
    GHRP-6
    Outcome
    IncreaseFeeding behavior after subcutaneous GHRP-6
    Study

    ratn: not reported in source

    satiated rats
    Outcome group
    Appetite and food intake · Metabolic and weight
    Studied dose
    Dose not stated · subcutaneousAs given in this study (rat).

    Source sentences

    Summary
    Two well-known hexapeptides, GHRP-6 and hexarelin, given s.c., dose dependently stimulated both GH release and feeding behavior in satiated rats.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In satiated rats, subcutaneous hexarelin stimulated GH release in a dose-dependent manner.

    In plain wordsIn rats, hexarelin injected under the skin raised growth hormone release as the dose went up.

    Peptide
    Hexarelin
    Outcome
    IncreaseGH release
    Study

    ratn: not reported in source

    satiated rats
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated · subcutaneousAs given in this study (rat).

    Source sentences

    Summary
    Two well-known hexapeptides, GHRP-6 and hexarelin, given s.c., dose dependently stimulated both GH release and feeding behavior in satiated rats.
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In satiated rats, subcutaneous hexarelin stimulated feeding behavior in a dose-dependent manner.

    In plain wordsIn rats that were not hungry, hexarelin injected under the skin made them eat more as the dose went up.

    Peptide
    Hexarelin
    Outcome
    IncreaseFeeding behavior
    Study

    ratn: not reported in source

    satiated rats
    Outcome group
    Appetite and food intake · Metabolic and weight
    Studied dose
    Dose not stated · subcutaneousAs given in this study (rat).

    Source sentences

    Summary
    Two well-known hexapeptides, GHRP-6 and hexarelin, given s.c., dose dependently stimulated both GH release and feeding behavior in satiated rats.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Versions 4 to 18Current

    28 Oct 2026, 02:02 UTC

    The same notice was added 15 times, first on 13 Oct 2026, 21:44 UTC. The status did not change between them.

    Study results updated

  2. Version 3

    13 Oct 2026, 16:31 UTC

    Study data updated · source update from Europe PMC

  3. Version 2

    12 Oct 2026, 12:58 UTC

    Study results updated

  4. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.